rewirebio.iobenchmarks
Protocol

Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC

Panel fragmentomic metrics computed on only genes shared with the FoundationOne Liquid CDx panel; one multinomial model per metric predicts Breast, Lung, Normal, Prostate.

13 evaluations · 65 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

13 recorded evaluations, 65 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

13 evaluations · 65 results. Different protocols are not a single leaderboard.

Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC · Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)

Sorted by AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.954 (best in column)1 (best in column)0.8960.9580.983 (best in column)
Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9531 (best in column)0.8930.9570.981
Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9470.9990.921 (best in column)0.962 (best in column)0.982
Normalised fragment read depth at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9451 (best in column)0.8860.9510.972
Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9360.9930.9140.9520.963
End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9330.9990.8680.9410.963
Normalised fragment read depth per gene, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9210.9990.8610.9360.964
Fragment-size Shannon entropy at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9070.9870.8740.9330.963
Fragment-length bin proportions at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9010.9910.850.9250.957
Fragment-size entropy at transcription factor binding sites, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.8970.9970.8670.930.958
Small-fragment proportion at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.8670.990.8860.9140.915
End-motif diversity score at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.8560.9990.8260.9020.928
Fragment-size entropy at cancer-specific open chromatin, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.8070.9730.7890.8710.916
All 65 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.954 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.896 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.958 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.983 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Combined', column 'Prostate'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.953 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Breast'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.893 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Lung'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.957 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Mean AUROC'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Normal'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.981 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Depth', column 'Prostate'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.933 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Breast'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.868 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Lung'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.941 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Mean AUROC'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Normal'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.963 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons MDS', column 'Prostate'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.947 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Breast'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.921 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Lung'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.962 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Mean AUROC'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Normal'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.982 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons SE', column 'Prostate'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.936 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Breast'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.914 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Lung'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.952 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Mean AUROC'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.993 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Normal'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, FoundationOne Liquid CDx gene subset: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.963 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; FoundationOne Liquid CDx genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail foundationone (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-foundationone

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'FoundationOne Liquid CDx', row 'All Exons Small Fragments', column 'Prostate'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Explore all linked results

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
3
External evaluations
10

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Select a task-valid null control after reviewing inputs and metric

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Select an upstream conventional reference after reviewing the full protocol

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-c8bea25e5abb. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-helzer2025-protocol-grail-foundationone.

Source locator: Supplementary Table S1; Results P7-P12; Methods P23

Related records

Suggest a correction